All 60 completed cases examined by ASCI between July and September 2026 violated its advertising code, highlighting widespread misleading claims
India’s nutraceutical market, valued at ₹3.67 trillion in 2025, is projected to reach ₹8.05 trillion by 2033, increasing the need for consumer protection
Weight-loss, anti-ageing and disease-related claims often promise unrealistic results, with some supplements positioned as safer alternatives to prescription therapies
Nutraceuticals accounted for 52% of food and beverage advertising cases in 2025-26, with 96% requiring modification
Self-regulation has limited deterrent power, while influencers, sponsored content and online marketplaces allow unsupported health claims to spread rapidly
FSSAI and consumer protection authorities must demand product-specific scientific evidence, independent testing and proportionate penalties for misleading claims